Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment/Experiment 4

From BugSigDB


Reviewed Marked as Reviewed by Claregrieve1 on 2022/06/22

Curated date: 2021/06/17

Curator: Madhubani Dey

Revision editor(s): Madhubani Dey, WikiWorks, Victoria

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Periodontitis chronic pericementitis,inflammation of periodontium,Pericementitides,Pericementitis,Periodontitides,periodontitis,Periodontitis (disorder),Periodontitis, NOS,periodontium inflammation,periodontosis,Periodontitis
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
Individuals diagnosed with both Periodontitis and Type 2 Diabetes and treated with metformin (Met group)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with both Periodontitis and Type 2 Diabetes who received metformin for at least 6 months and achieved glycemic control (HbA1c < 6.5%, without any companion diseases), were classified into the Met group
Group 0 sample size Number of subjects in the control (unexposed) group
27
Group 1 sample size Number of subjects in the case (exposed) group
20
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
patients treated with antibiotics within 3 months or those that received periodontal treatment within 6 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged

Signature 1

Reviewed Marked as Reviewed by Claregrieve1 on 2022/06/22

Curated date: 2021/06/27

Curator: Madhubani Dey

Revision editor(s): Madhubani Dey, Claregrieve1

Source: Supplementary Fig 3b

Description: Increased abundance of microbial communities in individuals in Met group compared to the controls

Abundance in Group 1: increased abundance in Individuals diagnosed with both Periodontitis and Type 2 Diabetes and treated with metformin (Met group)

NCBI Quality ControlLinks
Parvimonas micra
Peptostreptococcus stomatis
Prevotella denticola
Prevotella jejuni
Prevotella pallens
Segatella salivae
Solobacterium moorei
Treponema amylovorum
Treponema medium

Revision editor(s): Madhubani Dey, Claregrieve1